Literature DB >> 15351930

[Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].

N Ghanem1, T Kelly, C Altehoefer, J Winterer, O Schäfer, T A Bley, E Moser, M Langer.   

Abstract

PURPOSE: The aim of this study was to compare the diagnostic efficacy of whole-body magnetic resonance imaging (WB-MRI) as a new and rapid examination technique with skeletal scintigraphy for detection of skeletal metastases from solid tumors.
MATERIAL AND METHODS: In 129 patients with solid malignant tumors, WB-MRI was performed for individual comparison with skeletal scintigraphy. Examinations were performed with the innovative AngioSURF rolling table with integrated phased array surface coil and coronary TIRM sequences for different body regions.
RESULTS: The results for WB-MRI and skeletal scintigraphy were concordant in 81% of the cases, whereby both procedures excluded skeletal metastases in 43%. WB-MRI and skeletal scintigraphy demonstrated skeletal metastases in 38% of the cases, whereby WB-MRI provided more comprehensive findings in 45%. In 12% of the cases, skeletal scintigraphy was superior to WB-MRI and in 19% the findings were discordant, whereby WB-MRI detected skeletal metastases in 15 cases which had not been found on skeletal scintigraphy. In nine cases, skeletal scintigraphy was positive when the WB-MRI was negative. In 60% of the cases, WB-MRI evidenced tumor-associated findings.
CONCLUSION: WB-MRI represents a promising new staging technique for detection of skeletal metastases, which is more sensitive in many cases than skeletal scintigraphy in detecting and assessing the extent of skeletal metastases-and tumor-associated findings that are relevant for treatment strategy.

Entities:  

Mesh:

Year:  2004        PMID: 15351930     DOI: 10.1007/s00117-004-1096-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  24 in total

Review 1.  Whole-body MR imaging. Practical issues, clinical applications, and future directions.

Authors:  S J Eustace; R Walker; M Blake; E K Yucel
Journal:  Magn Reson Imaging Clin N Am       Date:  1999-05       Impact factor: 2.266

2.  Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography--initial experience.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Thomas C Lauenstein; Jörg F Debatin; Stefan G Ruehm
Journal:  Radiology       Date:  2003-02-19       Impact factor: 11.105

3.  Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.

Authors:  Masami Iizuka-Mikami; Kiyohisa Nagai; Koji Yoshida; Takashi Sugihara; Yoshimasa Suetsugu; Makoto Mikami; Tsutomu Tamada; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2004-02-18       Impact factor: 5.315

4.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

Review 5.  [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].

Authors:  J Bathmann; E Moser
Journal:  Radiologe       Date:  1995-01       Impact factor: 0.635

6.  Rapid magnetic resonance angiography for detection of atherosclerosis.

Authors:  S G Ruehm; M Goyen; J Barkhausen; K Kröger; S Bosk; M E Ladd; J F Debatin
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

7.  Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.

Authors:  R Walker; P Kessar; R Blanchard; M Dimasi; K Harper; V DeCarvalho; E K Yucel; L Patriquin; S Eustace
Journal:  J Magn Reson Imaging       Date:  2000-04       Impact factor: 4.813

8.  Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease.

Authors:  Christoph U Herborn; Mathias Goyen; Harald H Quick; Silke Bosk; Sandra Massing; Knut Kroeger; Dirk Stoesser; Stefan G Ruehm; Jörg F Debatin
Journal:  AJR Am J Roentgenol       Date:  2004-06       Impact factor: 3.959

9.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

10.  Metastatic and histologic presentations in unknown primary cancer.

Authors:  J S Nystrom; J M Weiner; J Heffelfinger-Juttner; L E Irwin; J R Bateman; R M Wolf
Journal:  Semin Oncol       Date:  1977-03       Impact factor: 4.929

View more
  8 in total

Review 1.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

Review 2.  [Magnetic resonance imaging in orthopaedic medicine].

Authors:  R Straub; M G Mack; V Jacobi; D Proschek; T J Vogl
Journal:  Orthopade       Date:  2006-06       Impact factor: 1.087

Review 3.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

4.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

5.  Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.

Authors:  Nadir Ghanem; Christian Lohrmann; Monika Engelhardt; Gregor Pache; Markus Uhl; Ulrich Saueressig; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2006-02-04       Impact factor: 5.315

Review 6.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 7.  [MRI in staging of lung cancer].

Authors:  C Hintze; J Biederer; H W Wenz; R Eberhardt; H U Kauczor
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

Review 8.  [Screening in cardiovascular diseases].

Authors:  H Kramer; S Weckbach; G van Kaick; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.